Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Centessa Pharmaceuticals PLC ADR

CNTA
Current price
8.1 USD -0.17 USD (-2.06%)
Last closed 8.27 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 934 873 920 USD
Yield for 12 month +77.24 %
1Y
3Y
5Y
10Y
15Y
CNTA
21.11.2021 - 28.11.2021

Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines for patients. Its products pipeline includes SerpinPC, an activated protein C inhibitor for the treatment of hemophilia A and B; and ORX750, an orally administered OX2R agonist for the treatment of narcolepsy and other sleep disorders. The company also develops LB101, a PD-L1xCD47 LockBody, a bi-specific monoclonal antibody for solid tumors, which is designed to selectively drive potent CD47 and CD3 effector function activity while avoiding systemic toxicity; and OX2R Agonists compounds are currently in development for the treatment of narcolepsy. In addition, its products pipeline comprises ORX750, an orally administered selective orexin receptor-2 (OX2R) agonist for the treatment of narcolepsy and other sleep disorders; and earlier-stage preclinical assets and discovery-stage programs. Centessa Pharmaceuticals plc was incorporated in 2020 and is headquartered in Altrincham, the United Kingdom. Address: 1 Ashley Road, Altrincham, United Kingdom, WA14 2DT

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

13.6 USD

P/E ratio

Dividend Yield

Current Year

+6 879 562 USD

Last Year

Current Quarter

Last Quarter

+6 912 614 USD

Current Year

+6 066 423 USD

Last Year

-130 919 USD

Current Quarter

-239 862 USD

Last Quarter

+6 664 475 USD

Key Figures CNTA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -170 972 992 USD
Operating Margin TTM -513.32 %
PE Ratio
Return On Assets TTM -26.61 %
PEG Ratio
Return On Equity TTM -52.79 %
Wall Street Target Price 13.6 USD
Revenue TTM 6 853 000 USD
Book Value 2.39 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -1.42 USD
Diluted Eps TTM -1.42 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics CNTA

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CNTA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation CNTA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 141.0346
Price Sales TTM 165.6886
Enterprise Value EBITDA -5.8426
Price Book MRQ 4.819

Financials CNTA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CNTA

For 52 weeks

4.3 USD 12.45 USD
50 Day MA 10.11 USD
Shares Short Prior Month 1 793 755
200 Day MA 8.16 USD
Short Ratio 7.04
Shares Short 1 763 646
Short Percent 2.06 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

430.32 USD Microsoft Corporation +0.69 (+0.16%)
Detailed analytics

ETF funds


S

SX7EEX

14.75 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) 0 (0%)
Detailed analytics

Metals


Gold

2357.98 USD Gold +6.23 (+0.27%)
Detailed analytics